The latest from Washington, D.C., impacting the insurance and financial services industries.
The Trump tariffs will dampen gross domestic product growth not only for the U.S. but for the rest of the world, The Conference Board said.
Tariffs have radically altered Morningstar’s second-quarter U.S. economic outlook as the organization’s chief U.S. economist said President Donald Trump’s proposed tariffs have pushed projected gross domestic product down, pushed projected inflation rates up and increased the risk of a recession to 40%.
As tariffs are under greater consideration, let’s examine their historical significance and explore potential implications of new tariff measures.
The Trump tariffs will dampen gross domestic product growth not only for the U.S. but for the rest of the world, The Conference Board said.
Tariffs have radically altered Morningstar’s second-quarter U.S. economic outlook as the organization’s chief U.S. economist said President Donald Trump’s proposed tariffs have pushed projected gross domestic product down, pushed projected inflation rates up and increased the risk of a recession to 40%.
As tariffs are under greater consideration, let’s examine their historical significance and explore potential implications of new tariff measures.
Market volatility can affect investors in a variety of ways, depending on their financial situation and where they are in their financial life cycle.
Medicare Advantage plans increasingly rely on middlemen for marketing, a move that is hiking costs and making it more difficult for government to oversee and regulate the health plans that millions of older Americans rely on. That was among the findings of a report released last week by Sen. Ron Wyden, D-Ore., the ranking member of the Senate Finance Committee.
Tariffs and fear over uncertainty are driving market volatility, a panel of experts said.
Michigan Republican urges the Trump administration’s newly confirmed Department of Labor Secretary to rescind the fiduciary rule.
The Trump administration proposed shortening the annual enrollment period for Affordable Care Act health insurance by one month, a move that one group warned could lead to more than 1 million Americans at risk of losing coverage.
Tesla owners may face increasing auto insurance premiums due to rising reports of vandalism directed at Tesla CEO Elon Musk.
Two professional associations representing health agents and brokers came out against the Medicare Payment Advisory Commission’s view of those who enroll consumers in coverage.
The insurance industry is facing even broader repercussions from the administration’s policies well beyond what tariffs could bring.
The National Association of Benefits and Insurance Professionals and a coalition of leading insurance and benefits organizations have sent a joint letter to congressional leaders urging immediate action to address growing concerns in the Medicare Advantage market.
Robert F. Kennedy Jr. has been tasked with leading the charge of making America healthy again? How might he do it?
The Trump administration needs revenue to offset planned trillion-dollar tax cuts. Could they look at retirement accounts?
The National Association of Benefits and Insurance Professionals will gather next week for its annual Capitol Conference, with a long list of issues its members will discuss with their representatives in Congress.
House Republicans proposed slashing Medicaid as a way to pay for federal budget cuts that would fund a GOP agenda that includes tax cuts, border security and energy production.
The U.S. economy is showing momentum in early 2025, despite lingering uncertainty in the wake of the November elections.
Health insurers and consumers both have a big stake in whether enhanced premium tax credits for coverage on the Affordable Care Act marketplace will continue.
Republican Rep. Troy Downing has made abolishing the Treasury Department’s Federal Insurance Office his priority as a freshman congressman.
The list, which includes 15 drugs, up from 10 last year, is the first step in a negotiation process between Medicare and drugmakers that is expected to take place over the coming months. The new negotiated prices won’t take effect until 2027.
